Skip to main content
Top
Published in: Osteoporosis International 5/2012

01-05-2012 | Original Article

Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial

Authors: T. Saarto, H. Sievänen, P. Kellokumpu-Lehtinen, R. Nikander, L. Vehmanen, R. Huovinen, H. Kautiainen, S. Järvenpää, H. M. Penttinen, M. Utriainen, A. S. Jääskeläinen, A. Elme, J. Ruohola, T. Palva, H. Vertio, M. Rautalahti, M. Fogelholm, R. Luoto, C. Blomqvist

Published in: Osteoporosis International | Issue 5/2012

Login to get access

Abstract

Summary

The ability of combined step aerobic- and circuit-training to prevent bone loss after breast cancer treatments was related to skeletal site and patients’ menopausal status. Among premenopausal breast cancer survivors, a 12-month exercise intervention completely prevented bone loss at the femoral neck, whereas no exercise effect was seen at lumbar spine or at neither site in postmenopausal women.

Introduction

The primary objective of this randomised clinical trial was to determine the preventive effect of supervised weight-bearing jumping exercises and circuit training on bone loss among breast cancer patients.

Methods

Of 573 breast cancer survivors aged 35–68 years randomly allocated into exercise or control group after adjuvant treatments, 498 (87%) were included in the final analysis. The 12-month exercise intervention comprised weekly supervised step aerobic- and circuit-exercises and similar home training. Bone mineral density (BMD) at lumbar spine and femoral neck were measured by dual-energy X-ray absorptiometry. Physical performance was assessed by 2-km walking and figure-8 running tests, and the amount of physical activity was estimated in metabolic equivalent-hours/week.

Results

In premenopausal women, bone loss at the femoral neck was prevented by exercise, the mean BMD changes being −0.2% among the trainees vs. −1.4% among the controls (p = 0.01). Lumbar bone loss could not be prevented (−1.9% vs. −2.2%). In postmenopausal women, no significant exercise-effect on BMD was found either at the lumbar spine (−1.6% vs. −2.1%) or femoral neck (−1.1% vs. −1.1%).

Conclusions

This 12-month aerobic jumping and circuit training intervention completely prevented femoral neck bone loss in premenopausal breast cancer patients, whereas no effect on BMD was seen in postmenopausal women.
Literature
1.
go back to reference Chen Z, Maricic M, Bassford TL et al (2005) Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study. Arch Intern Med 165:552–558PubMedCrossRef Chen Z, Maricic M, Bassford TL et al (2005) Fracture risk among breast cancer survivors: results from the Women’s Health Initiative Observational Study. Arch Intern Med 165:552–558PubMedCrossRef
2.
go back to reference Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179–1181PubMedCrossRef Kanis JA, McCloskey EV, Powles T, Paterson AH, Ashley S, Spector T (1999) A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 79:1179–1181PubMedCrossRef
3.
go back to reference Saarto T, Blomqvist C, Välimäki M, Mäkelä P, Sarna S, Elomaa I (1997) Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 15:1341–1347PubMed Saarto T, Blomqvist C, Välimäki M, Mäkelä P, Sarna S, Elomaa I (1997) Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients. J Clin Oncol 15:1341–1347PubMed
4.
go back to reference Saarto T, Vehmanen L, Blomqvist C, Elomaa I (2008) Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer. J Clin Oncol 26:4289–4295PubMedCrossRef Saarto T, Vehmanen L, Blomqvist C, Elomaa I (2008) Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer. J Clin Oncol 26:4289–4295PubMedCrossRef
5.
go back to reference Shapiro CL, Manola J, Leboff M (2001) Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 19:3306–3311PubMed Shapiro CL, Manola J, Leboff M (2001) Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 19:3306–3311PubMed
6.
go back to reference Vehmanen L, Saarto T, Blomqvist C, Mäkelä P, Välimäki M, Elomaa I (2001) Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment. Eur J Cancer 37:2373–2378PubMedCrossRef Vehmanen L, Saarto T, Blomqvist C, Mäkelä P, Välimäki M, Elomaa I (2001) Long-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment. Eur J Cancer 37:2373–2378PubMedCrossRef
7.
go back to reference Coleman RE, Banks LM, Girgis SI et al (2007) Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study. Lancet Oncol 8:119–127PubMedCrossRef Coleman RE, Banks LM, Girgis SI et al (2007) Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study. Lancet Oncol 8:119–127PubMedCrossRef
8.
go back to reference Lester J, Dodwell D, McCloskey E, Coleman R (2005) The causes and treatment of bone loss associated with carcinoma of the breast. Cancer Treat Rev 31:115–142PubMedCrossRef Lester J, Dodwell D, McCloskey E, Coleman R (2005) The causes and treatment of bone loss associated with carcinoma of the breast. Cancer Treat Rev 31:115–142PubMedCrossRef
9.
go back to reference Lonning PE, Geisler J, Krag LE et al (2005) Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol 23:5126–5137PubMedCrossRef Lonning PE, Geisler J, Krag LE et al (2005) Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer. J Clin Oncol 23:5126–5137PubMedCrossRef
10.
go back to reference Perez EA, Josse RG, Pritchard KI et al (2006) Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol 24:3629–3635PubMedCrossRef Perez EA, Josse RG, Pritchard KI et al (2006) Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17. J Clin Oncol 24:3629–3635PubMedCrossRef
11.
go back to reference Wolff I, van Croonenborg JJ, Kemper HC, Kostense PJ, Twisk JW (1999) The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 9:1–12PubMedCrossRef Wolff I, van Croonenborg JJ, Kemper HC, Kostense PJ, Twisk JW (1999) The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int 9:1–12PubMedCrossRef
12.
go back to reference Nikander R, Sievanen H, Heinonen A, Daly RM, Uusi-Rasi K, Kannus P (2010) Targeted exercise against osteoporosis: a systematic review and meta-analysis for optimising bone strength throughout life. BMC Med 8:47PubMedCrossRef Nikander R, Sievanen H, Heinonen A, Daly RM, Uusi-Rasi K, Kannus P (2010) Targeted exercise against osteoporosis: a systematic review and meta-analysis for optimising bone strength throughout life. BMC Med 8:47PubMedCrossRef
13.
go back to reference Karinkanta S, Piirtola M, Sievanen H, Uusi-Rasi K, Kannus P (2010) Physical therapy approaches to reduce fall and fracture risk among older adults. Nat Rev Endocrinol 6:396–407PubMedCrossRef Karinkanta S, Piirtola M, Sievanen H, Uusi-Rasi K, Kannus P (2010) Physical therapy approaches to reduce fall and fracture risk among older adults. Nat Rev Endocrinol 6:396–407PubMedCrossRef
14.
go back to reference Waltman NL, Twiss JJ, Ott CD et al (2010) The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. Osteoporos Int 21:1361–1369PubMedCrossRef Waltman NL, Twiss JJ, Ott CD et al (2010) The effect of weight training on bone mineral density and bone turnover in postmenopausal breast cancer survivors with bone loss: a 24-month randomized controlled trial. Osteoporos Int 21:1361–1369PubMedCrossRef
15.
go back to reference Winters-Stone KM, Schwartz A, Nail LM (2010) A review of exercise interventions to improve bone health in adult cancer survivors. J Cancer Surviv 4:187–201PubMedCrossRef Winters-Stone KM, Schwartz A, Nail LM (2010) A review of exercise interventions to improve bone health in adult cancer survivors. J Cancer Surviv 4:187–201PubMedCrossRef
16.
go back to reference Irwin ML, Alvarez-Reeves M, Cadmus L et al (2009) Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity (Silver Spring) 17:1534–1541CrossRef Irwin ML, Alvarez-Reeves M, Cadmus L et al (2009) Exercise improves body fat, lean mass, and bone mass in breast cancer survivors. Obesity (Silver Spring) 17:1534–1541CrossRef
17.
go back to reference Schwartz AL, Winters-Stone K, Gallucci B (2007) Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 34:627–633PubMedCrossRef Schwartz AL, Winters-Stone K, Gallucci B (2007) Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 34:627–633PubMedCrossRef
18.
go back to reference Penttinen H, Nikander R, Blomqvist C, Luoto R, Saarto T (2009) Recruitment of breast cancer survivors into a 12-month supervised exercise intervention is feasible. Contemp Clin Trials 30:457–463PubMedCrossRef Penttinen H, Nikander R, Blomqvist C, Luoto R, Saarto T (2009) Recruitment of breast cancer survivors into a 12-month supervised exercise intervention is feasible. Contemp Clin Trials 30:457–463PubMedCrossRef
19.
go back to reference Rosendahl M, Ahlgren J, Andersen J et al (2009) The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000–1 study. Eur J Cancer 45:3198–204PubMedCrossRef Rosendahl M, Ahlgren J, Andersen J et al (2009) The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000–1 study. Eur J Cancer 45:3198–204PubMedCrossRef
20.
go back to reference Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R et al (2009) Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial. Lancet Oncol 10:1145–1151PubMedCrossRef Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R et al (2009) Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial. Lancet Oncol 10:1145–1151PubMedCrossRef
21.
go back to reference Nikander R, Sievanen H, Ojala K, Oivanen T, Kellokumpu-Lehtinen PL, Saarto T (2007) Effect of a vigorous aerobic regimen on physical performance in breast cancer patients—a randomized controlled pilot trial. Acta Oncol 46:181–186PubMedCrossRef Nikander R, Sievanen H, Ojala K, Oivanen T, Kellokumpu-Lehtinen PL, Saarto T (2007) Effect of a vigorous aerobic regimen on physical performance in breast cancer patients—a randomized controlled pilot trial. Acta Oncol 46:181–186PubMedCrossRef
22.
go back to reference Vainionpaa A, Korpelainen R, Vihriälä E, Rinta-Paavola A, Leppäluoto J, Jämsä T (2006) Intensity of exercise is associated with bone density change in premenopausal women. Osteoporos Int 17:455–463PubMedCrossRef Vainionpaa A, Korpelainen R, Vihriälä E, Rinta-Paavola A, Leppäluoto J, Jämsä T (2006) Intensity of exercise is associated with bone density change in premenopausal women. Osteoporos Int 17:455–463PubMedCrossRef
23.
go back to reference Weeks BK, The BBR (2008) BPAQ, a bone-specific physical activity assessment instrument. Osteoporos Int 19:1567–1577PubMedCrossRef Weeks BK, The BBR (2008) BPAQ, a bone-specific physical activity assessment instrument. Osteoporos Int 19:1567–1577PubMedCrossRef
24.
go back to reference Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504PubMedCrossRef Ainsworth BE, Haskell WL, Whitt MC et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32:S498–S504PubMedCrossRef
25.
go back to reference Baranowski T, Smith M, Thompson WO, Baranowski J, Hebert D, de Moor C (1999) Intraindividual variability and reliability in a 7-day exercise record. Med Sci Sports Exerc 31:1619–1622PubMedCrossRef Baranowski T, Smith M, Thompson WO, Baranowski J, Hebert D, de Moor C (1999) Intraindividual variability and reliability in a 7-day exercise record. Med Sci Sports Exerc 31:1619–1622PubMedCrossRef
26.
go back to reference Oja P, Laukkanen R, Pasanen M, Tyry T, Vuori I (1991) A 2-km walking test for assessing the cardiorespiratory fitness of healthy adults. Int J Sports Med 12:356–362PubMedCrossRef Oja P, Laukkanen R, Pasanen M, Tyry T, Vuori I (1991) A 2-km walking test for assessing the cardiorespiratory fitness of healthy adults. Int J Sports Med 12:356–362PubMedCrossRef
27.
go back to reference Tegner Y, Lysholm J, Lysholm M, Gillquist J (1986) A performance test to monitor rehabilitation and evaluate anterior cruciate ligament injuries. Am J Sports Med 14:156–159PubMedCrossRef Tegner Y, Lysholm J, Lysholm M, Gillquist J (1986) A performance test to monitor rehabilitation and evaluate anterior cruciate ligament injuries. Am J Sports Med 14:156–159PubMedCrossRef
28.
go back to reference Vartiainen MV, Rinne MB, Lehto TM, Pasanen ME, Sarajuuri JM, Alaranta HT (2006) The test-retests reliability of motor performance measures after traumatic brain injury. Adv Physiother 8:50–59CrossRef Vartiainen MV, Rinne MB, Lehto TM, Pasanen ME, Sarajuuri JM, Alaranta HT (2006) The test-retests reliability of motor performance measures after traumatic brain injury. Adv Physiother 8:50–59CrossRef
29.
go back to reference Covey MK, Smith DL, Berry JK, Hacker ED (2008) Importance of cross-calibration when replacing DXA scanners: QDR4500W and Discovery Wi. J Nurs Meas 16:155–170PubMedCrossRef Covey MK, Smith DL, Berry JK, Hacker ED (2008) Importance of cross-calibration when replacing DXA scanners: QDR4500W and Discovery Wi. J Nurs Meas 16:155–170PubMedCrossRef
30.
go back to reference Fan B, Lewiecki EM, Sherman M et al (2008) Improved precision with Hologic Apex software. Osteoporos Int 19:1597–1602PubMedCrossRef Fan B, Lewiecki EM, Sherman M et al (2008) Improved precision with Hologic Apex software. Osteoporos Int 19:1597–1602PubMedCrossRef
31.
go back to reference Vehmanen L, Elomaa I, Blomqvist C, Saarto T (2006) Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 24:675–680PubMedCrossRef Vehmanen L, Elomaa I, Blomqvist C, Saarto T (2006) Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 24:675–680PubMedCrossRef
32.
go back to reference Frost HM (2003) Bone’s mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol 275:1081–1101PubMedCrossRef Frost HM (2003) Bone’s mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol 275:1081–1101PubMedCrossRef
33.
go back to reference Heinonen A, Oja P, Kannus P, Sievanen H, Manttari A, Vuori I (1993) Bone mineral density of female athletes in different sports. Bone Miner 23:1–14PubMedCrossRef Heinonen A, Oja P, Kannus P, Sievanen H, Manttari A, Vuori I (1993) Bone mineral density of female athletes in different sports. Bone Miner 23:1–14PubMedCrossRef
34.
go back to reference Sievanen H, Koskue V, Rauhio A, Kannus P, Heinonen A, Vuori I (1998) Peripheral quantitative computed tomography in human long bones: evaluation of in vitro and in vivo precision. J Bone Miner Res 13:871–882PubMedCrossRef Sievanen H, Koskue V, Rauhio A, Kannus P, Heinonen A, Vuori I (1998) Peripheral quantitative computed tomography in human long bones: evaluation of in vitro and in vivo precision. J Bone Miner Res 13:871–882PubMedCrossRef
35.
go back to reference Uusi-Rasi K, Kannus P, Cheng S et al (2003) Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial. Bone 33:132–143PubMedCrossRef Uusi-Rasi K, Kannus P, Cheng S et al (2003) Effect of alendronate and exercise on bone and physical performance of postmenopausal women: a randomized controlled trial. Bone 33:132–143PubMedCrossRef
36.
go back to reference Heinonen A, Kannus P, Sievanen H et al (1996) Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 348:1343–1347PubMedCrossRef Heinonen A, Kannus P, Sievanen H et al (1996) Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 348:1343–1347PubMedCrossRef
37.
go back to reference Bassey EJ, Rothwell MC, Littlewood JJ, Pye DW (1998) Pre- and postmenopausal women have different bone mineral density responses to the same high-impact exercise. J Bone Miner Res 13:1805–1813PubMedCrossRef Bassey EJ, Rothwell MC, Littlewood JJ, Pye DW (1998) Pre- and postmenopausal women have different bone mineral density responses to the same high-impact exercise. J Bone Miner Res 13:1805–1813PubMedCrossRef
38.
go back to reference Sugiyama T, Yamaguchi A, Kawai S (2002) Effects of skeletal loading on bone mass and compensation mechanism in bone: a new insight into the “mechanostat” theory. J Bone Miner Metab 20:196–200PubMedCrossRef Sugiyama T, Yamaguchi A, Kawai S (2002) Effects of skeletal loading on bone mass and compensation mechanism in bone: a new insight into the “mechanostat” theory. J Bone Miner Metab 20:196–200PubMedCrossRef
39.
go back to reference Goto S, Shigeta H, Hyakutake S, Yamagata M (1996) Comparison between menopause-related changes in bone mineral density of the lumbar spine and the proximal femur in Japanese female athletes: a long-term longitudinal study using dual-energy X-Ray absorptiometry. Calcif Tissue Int 59:461–465PubMed Goto S, Shigeta H, Hyakutake S, Yamagata M (1996) Comparison between menopause-related changes in bone mineral density of the lumbar spine and the proximal femur in Japanese female athletes: a long-term longitudinal study using dual-energy X-Ray absorptiometry. Calcif Tissue Int 59:461–465PubMed
41.
42.
go back to reference Jarvinen TL, Sievanen H, Jokihaara J, Einhorn TA (2005) Revival of bone strength: the bottom line. J Bone Miner Res 20:717–720PubMedCrossRef Jarvinen TL, Sievanen H, Jokihaara J, Einhorn TA (2005) Revival of bone strength: the bottom line. J Bone Miner Res 20:717–720PubMedCrossRef
43.
go back to reference Turner CH, Owan I, Takano Y (1995) Mechanotransduction in bone: role of strain rate. Am J Physiol 269:E438–E442PubMed Turner CH, Owan I, Takano Y (1995) Mechanotransduction in bone: role of strain rate. Am J Physiol 269:E438–E442PubMed
44.
go back to reference Cadmus LA, Salovey P, Yu H, Chung G, Kasl S, Irwin ML (2009) Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials. Psychooncology 18:343–352PubMedCrossRef Cadmus LA, Salovey P, Yu H, Chung G, Kasl S, Irwin ML (2009) Exercise and quality of life during and after treatment for breast cancer: results of two randomized controlled trials. Psychooncology 18:343–352PubMedCrossRef
45.
go back to reference Courneya KS, Segal RJ, Mackey JR et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25:4396–4404PubMedCrossRef Courneya KS, Segal RJ, Mackey JR et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25:4396–4404PubMedCrossRef
46.
go back to reference Markes M, Brockow T, Resch KL (2006) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev CD005001 Markes M, Brockow T, Resch KL (2006) Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev CD005001
47.
go back to reference McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 175:34–41PubMedCrossRef McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS (2006) Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 175:34–41PubMedCrossRef
Metadata
Title
Effect of supervised and home exercise training on bone mineral density among breast cancer patients. A 12-month randomised controlled trial
Authors
T. Saarto
H. Sievänen
P. Kellokumpu-Lehtinen
R. Nikander
L. Vehmanen
R. Huovinen
H. Kautiainen
S. Järvenpää
H. M. Penttinen
M. Utriainen
A. S. Jääskeläinen
A. Elme
J. Ruohola
T. Palva
H. Vertio
M. Rautalahti
M. Fogelholm
R. Luoto
C. Blomqvist
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 5/2012
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-011-1761-4

Other articles of this Issue 5/2012

Osteoporosis International 5/2012 Go to the issue